Transplantation of human bone marrow mesenchymal stem cells (hMSCs) stands as a
potent stroke therapy, but its exact mechanism remains unknown. This study investigated the …

Mesenchymal stem cells (MSCs) have been successfully used for the treatment of
experimental stroke. However, the neurorestorative mechanisms by which MSCs improve …

Intravenous transplantation of mesenchymal stem cells (MSCs) prepared from bone marrow
ameliorates functional deficits in rat cerebral infarction models. Although several hypotheses …

We analyzed the cell characteristics, neuroprotective, and transplantation effects of human
cranial bonederived mesenchymal stem cells (hcMSCs) in ischemic stroke model rats …

Bone marrow mesenchymal stem cells (BMSCs) are mainly administered via three routes:
intra-arterial, intravenous and intracerebral. It has been reported that BMSC administration …

Cerebral ischemia, which may lead to cerebral hypoxia and damage of the brain tissue, is a
leading cause of human mortality and adult disability. Mesenchymal stem cells (MSCs) are a …

Mesenchymal stem cells (MSC) from bone marrow induce neuroprotective effects and
improve clinical symptoms in animal models for acute cerebral ischemia. So far only few …

Although intravenous delivery of mesenchymal stem cells (MSCs) prepared from adult bone
marrow reduces infarction size and ameliorates functional deficits in rat middle cerebral …

There is now evidence to suggest that bone marrow mesenchymal stem cells (MSCs) not
only differentiate into mesodermal cells, but can also adopt the fate of endodermal and …

Background Several lines of evidence have demonstrated that bone marrow-derived
mesenchymal stem cells (BM-MSC) release bioactive factors and provide neuroprotection …